Clinical Trial Update: Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the combination of perindopril and telmisartan for treating nonalcoholic fatty liver disease; the current status is not d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• Telmisartan (Telmisartan)
• perindopril (perindopril)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Nonalcoholic Fatty Liver Disease (NAFLD) | Phase 4 | Status: UNKNOWN